chevron_leftBack
As of 13 June 2026, TherapeuticsMD, Inc. has a market cap of $24.42M USD, ranking #35668 globally and #4889 in the United States.
It ranks #3213 in the Healthcare sector, and #1082 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$24.42MUSD
Enterprise Value
$23.04MUSD
Revenue (TTM)
$3.02MUSD
EBITDA (TTM)
-$1.98MUSD
Net Income (TTM)
-$569.0KUSD
EBITDA Margin
-66%
Profit Margin
-19%
PS Ratio
8.1
PB Ratio
0.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Marlan Walker
open_in_new
Employees
1
Founded
2008
Website
therapeuticsmd.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.5% | -5% | -1.4% | -3.3% | 66% | 70% |
News
Loading...
TXMD Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
TXMD
TherapeuticsMD Inc
ISIN: US88338N2062
Shares Out.:
Shares Outstanding:
11.574M1
Shares Float:
10.78M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.11 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
3M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
NYSE: MRK
|
$274.03B
1M%
|
15.1
|
|
NYSE: PFE
|
$149.38B
612K%
|
19.5
|
|
NYSE: BMY
|
$117.58B
481K%
|
16.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: RO
|
$321.52B
1M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
1M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
1M%
218.9B CHF
|
20.5
|
|
CPH: NOVO-B
|
$181.82B
744K%
1.18T DKK
|
11.5
|
|
EPA: SAN
|
$110.1B
451K%
95.26B EUR
|
19.9
|
|
LSE: GSK
|
$108.46B
444K%
80.96B GBP
|
14.6
|
chevron_leftBack